UK quantum computing has become one of the most strategically important corners of early-stage tech. The UK has world-class research, strong government support and a growing investor pool focused on deep tech. But the category is capital-intensive, scientifically complex and requires patient capital — generalist VCs rarely have the expertise.
A venture capital firm is a professional fund that invests pooled capital into high-growth startups in exchange for equity. Unlike angels investing their own money, VCs deploy capital on behalf of LPs — institutional investors, family offices and corporates. That shapes how they make decisions, the cheque sizes they write and the returns they expect.
UK quantum VC cheques typically range from £1m to £15m at early stages, with significant grant stacking through the National Quantum Technologies Programme. Diligence runs eight to sixteen weeks with deep scientific review, IP analysis and commercial roadmap assessment. Expect milestone-based tranches and board engagement on both science and commercialisation.
Not every VC is the right VC for Quantum Computing. When building a shortlist, compare them on:
Relevance beats reach. A sector-aligned VC will move faster, ask sharper questions and bring more than capital.
UK quantum capital has grown meaningfully with dedicated funds, government support and corporate VCs. But it remains highly specialist — founders chasing generalist VCs waste months. Targeting the right investor pool shortens fundraising dramatically.
Fit starts before the first meeting. Check each VC's recent investments, whether they led or followed and how portfolio founders describe the partnership post-close. Warm intros still matter — but the best ones come from shared context, not generic requests. A tight list of ten aligned VCs will outperform scattered outreach to fifty every time, especially in a tougher funding environment.
The right quantum VC will back you through the long science arc, help stack non-dilutive capital and bring the strategic relationships that turn research into commercial, deployable quantum capability.
Kelvin Capital was founded in 2009 and has since raised a total of over £113 million into 33 portfolio companies.
We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to our investors.
We also invest in companies that require capital to grow their business.
For the right company with the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business.
Blackfinch Group is an award-winning investment specialist and trusted provider. Employing more than 150 full-time members of staff, it has a heritage dating back 30 years. The group provides tax-efficient investment solutions, managed portfolio services, early-stage investing, property financing and energy infrastructure investing. It is entrusted with over £850million in assets under management, as of February 2025.
Inspired by the work of Charles Darwin and founded on evolutionary principles, Blackfinch adapts to and evolves with customer requirements, helping others to thrive.
At ACT Venture Partners, we invest in the early stages of deep-tech,when the science is promising, the market is still forming, and the belief is not yet widespread.
From quantum communication to AI-powered biology, from climate infrastructure to advanced sensing,we partner with technical founders who turn hard science into real-world impact.
We exist to catalyze that transformation.
We invest at pre-seed and seed, often as the first institutional investor, with initial checks ranging from €500K to €1.5M. We don’t wait for traction, we invest on conviction. We’re not chasing trends, we’re
building the foundation of the next industrial wave.
When we founded AlbionVC in 1996 we set out to partner with visionary entrepreneurs to create successful companies across a range of industries.
A lot has changed since, however the way we do business has not. We are supportive investors, not operators, who strive for excellence and show ethics and humility in our interactions with founders and with each other.
We invest in startups with potential to grow into enduring companies that reshape industries. In doing so we achieve top quartile returns for our investors.
Today we focus on the software, healthcare and deeptech in the UK. The knowledge and insights we have built up over the last 29 years have given us an ability to spot companies that are set to become global category leaders. And have shaped our understanding of the tools & support we can offer them on their journey.
All of this is only possible because of the long term, considerate yet high performing culture, embodied by an inspiring team, half of whom have been doing this for well over a decade.
Since 1997, Amadeus Capital Partners has backed more than 190 pioneering companies and raised over $1.3 billion to fuel their growth. We’re a team of investors and entrepreneurs driven by curiosity, partnership, and the transformative power of technology.
We invest in trailblazers – founders turning bold ideas into global impact. Our portfolio spans breakthrough businesses such as Cryptosense, the global leader in cryptography management software (acquired by SandboxAQ); Igenomix in reproductive genetics (acquired by EQT); CSR’s single-chip Bluetooth innovation (acquired by Qualcomm); and VocalIQ, a speech recognition company (acquired by Apple).
From intelligence and human potential to the future of the planet, we back deep tech companies redefining what’s possible.
